NWM
PFE icon

Nova Wealth Management’s Pfizer PFE Stock Holding History

Nova Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Buy
+139
New +$3.64K ﹤0.01% 493
2025
Q3 		– Sell
-95
Closed -$2.3K – 711
2025
Q2 		$2.3K Buy
+95
New +$2.22K ﹤0.01% 543

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Nova Wealth Management's PFE Position: Q2 2026 in Review

Nova Wealth Management opened a new position in Pfizer (PFE) in Q2 2026: 139 shares worth $3.35K. The stake represents ﹤0.01% of the portfolio and ranks #493 among its holdings. This is a return to the name: Nova Wealth Management previously reported a position in PFE as recently as Q2 2025.

Nova Wealth Management first reported a position in PFE in Q2 2025 and has held it in 2 quarters since. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Nova Wealth Management held 139 shares of Pfizer worth $3.35K as of Q2 2026.
  • Pfizer was a new Nova Wealth Management position in Q2 2026.
  • Pfizer made up ﹤0.01% of Nova Wealth Management's portfolio in Q2 2026, its #493 holding.
  • Nova Wealth Management first reported a position in Pfizer in Q2 2025 and has held it in 2 quarters since.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nova Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.